---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-23-017025"
form_type: "8-K"
ticker: "SKIN"
cik: "0001818093"
company_name: "SkinHealth Systems Inc."
filed_at: "2023-05-10T23:59:59+00:00"
generated_at: "2026-06-15T06:56:26.511586+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# BeautyHealth Q1 net sales $86.3M (+14% YoY), net loss $22.3M, raises FY23 guidance

## Summary
- Net sales $86.3M (+14% YoY); consumables +21% YoY led by Americas +34% and EMEA +35% ex-Russia.
- Net loss $22.3M vs net income $31.5M in prior year; adjusted EBITDA loss $0.5M vs +$1.2M.
- GAAP gross margin 62.7% (down from 67.5%); adjusted gross margin 70.0% (down from 71.3%).
- Company raises FY2023 net sales guidance and reaffirms EBITDA margin and 2025 long-term targets.
- Syndeo international launch planned for Q2 2023; China COVID shutdowns affected Jan-Feb but rebound in March.

## SEC filing metadata
- accession: 0001628280-23-017025
- form_type: 8-K
- ticker: SKIN
- cik: 0001818093
- company_name: SkinHealth Systems Inc.
- filed_at: 2023-05-10T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1818093/000162828023017025/0001628280-23-017025-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1818093/000162828023017025/skin-20230510.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-23-017025
- JSON: https://secwatch.observer/filing/0001628280-23-017025.json
- Plain text: https://secwatch.observer/filing/0001628280-23-017025.txt

## Key facts
- Earnings Releases
  SkinHealth Systems Inc. reported the first quarter ended March 31, 2023 results: revenue $86.3 million, net income $(22.3) million. Guidance raised.
  - Period: the first quarter ended March 31, 2023
  - Revenue: $86.3 million
  - Net income: $(22.3) million
  - Guidance: raised
  - Result: reported results
  source text: BeautyHealth Reports First Quarter 2023 Financial Results On strong consumer demand, delivers double-digit net sales growth in line with 2023 plan Raises fiscal 2023 net sales guidance Long Beach, Calif., May 10, 2023 – The Beauty Health Company (NASDAQ: SKIN), home to flagship brand Hydrafacial, today announced financial results for the first quarter ended March 31, 2023. For the quarter, net sales of $86.3 million increased +14% year-over-year, continuing a trend of double-digit quarterly growth. On the momentum, the Company raises 2023 net sales guidance and reaffirms 2023 EBITDA margin and 2025 long-term targets. The quarter was underpinned by continued strong consumer demand for Hydrafacial treatments, with +21% year-over-year consumables net sales growth globally. Of note, consumables net sales grew +34% year-over-year in the Americas and +13% in EMEA. Excluding $1.2 million of Q1 2022 consumables net sales in Russia, growth in EMEA was +35%. In APAC, consumables net sales declin
  evidence_url: https://www.sec.gov/Archives/edgar/data/1818093/000162828023017025/0001628280-23-017025-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.